MDWD

13.5900.37%
SH

Shmulik Hess

COO & Chief Commercial Officer

Dr. Shmulik Hess, Ph.D., serves as Chief Operating Officer and Chief Commercial Officer at MediWound Ltd. since December 01, 2023. He served as Chief Executive Officer at Tabby Therapeutics, Enlivex Therapeutics and Valin Technologies. Formerly, Dr. Hess served as a global operations executive at SciGen Ltd. He was the Co-Founder and Chief Executive Officer at Active PX Ltd. Dr. Hess is the inventor of multiple patents and author of numerous publications in peer reviewed scientific journals. He received his Ph.D. in Pharmaceutical Science from the Hebrew University, Israel and was a research fellow at Harvard-MIT Health Sciences and Technology (HST).

Positions